Further sustaining a possible role of GSDMB in the pathogenesis of MS, the knockdown of GSDMB in memory CD4+ T-cells was shown to augment the production of cytokines such as tumor necrosis factor (TNF), interleukin (IL)-13, and IL-16 [61]. This evidence concerns the gene IL13 and myeloid sarcoma.